HealthDay News -- Atrial fibrillation (AF) patients under the age of 45 who undergo ablative therapy experience fewer major complications and similar efficacy as older patients, and have a higher chance of remaining AF free without the use of antiarrhythmic drugs (AADs), according to research published online Sept. 21 in Circulation: Arrhythmia and Electrophysiology.
